Prospects for reprogramming the immune system in multiple sclerosis

Prospects for reprogramming the immune system in multiple sclerosis

Opis bibliograficzny
1. autor:	Waldmann, H
Format:	Conference item
Wydane:	2007

Podobne zapisy

Reprogramming the immune system.
od: Waldmann, H
Wydane: (2008)

Reprogramming the immune system.
od: Waldmann, H
Wydane: (2002)

REPROGRAMMING THE IMMUNE-SYSTEM
od: Waldmann, H, i wsp.
Wydane: (1993)

Reprogramming the immune system using antibodies.
od: Graca, L, i wsp.
Wydane: (2006)

Reprogramming the immune system for tolerance with monoclonal antibodies.
od: Cobbold, S, i wsp.
Wydane: (1990)

Reprogramming the immune system towards regulation
od: Waldmann, H, i wsp.
Wydane: (2010)

Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
od: Waldmann, H, i wsp.
Wydane: (2008)

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
od: Cobbold, S, i wsp.
Wydane: (1992)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
od: Sofia Pereira das Neves, i wsp.
Wydane: (2023-10-01)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
od: Waldmann, H, i wsp.
Wydane: (1993)

Effect of puberty on the immune system: Relevance to multiple sclerosis
od: Carmen C. Ucciferri, i wsp.
Wydane: (2022-12-01)

Cortical injury in multiple sclerosis; the role of the immune system
od: Walker Caroline A, i wsp.
Wydane: (2011-12-01)

Immune-mediated genesis of multiple sclerosis
od: Salvatore Cavallo, MD, Specialist in Medical Genetics
Wydane: (2020-01-01)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
od: Chu-Yik Tang, i wsp.
Wydane: (2017-07-01)

THE INVERSION OF HOMEOSTATIC PROPERTIES OF THE IMMUNE SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS
od: I. I. Andreevа, i wsp.
Wydane: (2016-06-01)

CAMPATH-IH in multiple sclerosis.
od: Moreau, T, i wsp.
Wydane: (1996)

Prospects of siponimod in secondary progressive multiple sclerosis
od: Marisa McGinley, i wsp.
Wydane: (2018-07-01)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
od: Shaojie Wu, i wsp.
Wydane: (2021-01-01)

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
od: Alessandro Maglione, i wsp.
Wydane: (2019-10-01)

Role of innate immune cells in multiple sclerosis
od: Carolina Prado, i wsp.
Wydane: (2025-02-01)

Pulsed immune reconstitution therapy in multiple sclerosis
od: Per Soelberg Sorensen, i wsp.
Wydane: (2019-03-01)

Prospects for the use of curcumin as an additional treatment for multiple sclerosis
od: V. S. Rogovskii, i wsp.
Wydane: (2023-08-01)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
od: Moreau, T, i wsp.
Wydane: (1996)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
od: I. P. Ivanova, i wsp.
Wydane: (2021-10-01)

EBV-specific T-cell immunity: relevance for multiple sclerosis
od: Malina Behrens, i wsp.
Wydane: (2024-12-01)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
od: Norma Y. Hernández-Pedro, i wsp.
Wydane: (2013-01-01)

Acetate correlates with disability and immune response in multiple sclerosis
od: Silvia Pérez-Pérez, i wsp.
Wydane: (2020-11-01)

Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
od: Chao Wang, i wsp.
Wydane: (2023-02-01)

CD8+ T cells as immune regulators of multiple sclerosis
od: Sushmita eSinha, i wsp.
Wydane: (2015-12-01)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
od: Zijian Li, i wsp.
Wydane: (2021-03-01)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
od: Kyle K. Payne, i wsp.
Wydane: (2012-01-01)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
od: Cox, A, i wsp.
Wydane: (2005)

Understanding and Modulating Immunity With Cell Reprogramming
od: Cristiana F. Pires, i wsp.
Wydane: (2019-12-01)

The cancer metabolic reprogramming and immune response
od: Longzheng Xia, i wsp.
Wydane: (2021-02-01)

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens
od: Giulia Escobar, i wsp.
Wydane: (2018-07-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
od: I. V. Smagina, i wsp.
Wydane: (2010-08-01)

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
od: Jiwon Oh, i wsp.
Wydane: (2014-09-01)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
od: Jarius, S, i wsp.
Wydane: (2008)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
od: Wu S, i wsp.
Wydane: (2023-09-01)

Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
od: Songlei Zhou, i wsp.
Wydane: (2023-01-01)